07-11-2024 |
PM |
|
HAE |
Haemonetics Corporation |
3,840 |
1.12 |
1.09 |
0.99 |
Haemonetics Non-GAAP EPS of $1.12 beats by $0.05, revenue of $346M beats by $3.42M [11/7/2024 6:09 AM] |
86.69 |
8.53 (10.92%) |
81.35 |
3.19 (4.08%) |
70.25 - 97.97 |
1,364,414 |
640,000 |
1,174 |
|
|
08-08-2024 |
PM |
|
HAE |
Haemonetics Corporation |
4,380 |
1.02 |
1.03 |
1.05 |
Haemonetics Non-GAAP EPS of $1.02 beats by $0.01, revenue of $336.17M beats by $1.13M [8/8/2024 6:04 AM] |
76.41 |
-9.31 (-10.86%) |
0.0 |
0.0 (0.00%) |
70.74 - 97.97 |
2,082,824 |
470,000 |
0 |
|
|
09-05-2024 |
PM |
|
HAE |
Haemonetics Corporation |
4,830 |
0.90 |
0.88 |
0.77 |
Haemonetics Non-GAAP EPS of $0.90 beats by $0.01, revenue of $343.29M beats by $13.82M [5/9/2024 6:06 AM] |
92.26 |
-0.99 (-1.06%) |
0.0 |
0.0 (0.00%) |
70.74 - 97.12 |
726,678 |
540,000 |
0 |
|
|
08-02-2024 |
PM |
|
HAE |
Haemonetics Corporation |
3,910 |
1.04 |
0.97 |
0.85 |
Haemonetics beats Q3 top and bottom line estimates, updates guidance [2/8/2024 6:07 AM] |
77.98 |
0.87 (1.13%) |
79.02 |
1.91 (2.48%) |
74.13 - 95.26 |
1,062,747 |
470,000 |
0 |
|
|
02-11-2023 |
PM |
|
HAE |
Haemonetics Corporation |
4,320 |
0.99 |
0.94 |
0.83 |
Haemonetics Non-GAAP EPS of $0.99 beats by $0.10, revenue of $318M beats by $4.9M [11/2/2023 6:14 AM] |
85.46 |
-0.93 (-1.08%) |
85.46 |
0.0 (0.00%) |
72.26 - 95.26 |
605,108 |
290,000 |
9,672 |
|
|
08-08-2023 |
PM |
|
HAE |
Haemonetics Corporation |
4,540 |
1.05 |
0.76 |
0.58 |
Haemonetics Non-GAAP EPS of $1.05 beats by $0.32, revenue of $311.3M beats by $18.61M [8/8/2023 6:05 AM] |
89.72 |
1.07 (1.21%) |
91.01 |
2.36 (2.66%) |
67.27 - 95.26 |
607,091 |
250,000 |
1,353 |
|
|
11-05-2023 |
PM |
6:00 AM ET (May 11) |
HAE |
Haemonetics Corporation |
4,110 |
0.77 |
0.68 |
0.65 |
Haemonetics Non-GAAP EPS of $0.77 beats by $0.07, revenue of $304M beats by $13.21M [5/11/2023 6:14 AM] |
85.90 |
2.80 (3.37%) |
0.0 |
0.0 (0.00%) |
50.48 - 91.39 |
362,518 |
270,000 |
0 |
|
|
07-02-2023 |
PM |
6:00 AM ET (Feb 7) |
HAE |
Haemonetics Corporation |
4,370 |
0.85 |
0.79 |
0.84 |
Haemonetics Non-GAAP EPS of $0.85 beats by $0.03, revenue of $305.3M beats by $4.83M [2/7/2023 6:05 AM] |
82.19 |
-5.57 (-6.35%) |
88.00 |
0.24 (0.27%) |
45.96 - 91.39 |
907,692 |
470,000 |
2,350 |
|
|
07-11-2022 |
PM |
6:00 AM ET (Nov 7) |
HAE |
Haemonetics Corporation |
4,080 |
0.83 |
0.70 |
0.60 |
Haemonetics Non-GAAP EPS of $0.83 beats by $0.16, revenue of $297.48M beats by $28.26M [11/7/2022 6:05 AM] |
83.40 |
2.74 (3.40%) |
85.50 |
4.84 (6.00%) |
43.50 - 85.97 |
609,116 |
380,000 |
1,613 |
|
|
10-08-2022 |
PM |
6:00 AM ET (Aug 10) |
HAE |
Haemonetics Corporation |
3,390 |
0.58 |
0.53 |
0.50 |
Haemonetics reports FQ1 earnings beat; raises FY22 guidance [8/10/2022 6:09 AM] |
73.70 |
6.11 (9.04%) |
70.99 |
3.40 (5.03%) |
43.50 - 77.08 |
802,545 |
400,000 |
828 |
|
|
10-05-2022 |
PM |
6:00 AM ET (May 10) |
HAE |
Haemonetics Corporation |
2,650 |
0.65 |
0.60 |
0.46 |
Haemonetics Non-GAAP EPS of $0.65 beats by $0.05, revenue of $265M beats by $7.89M [5/10/2022 6:30 AM] |
53.76 |
4.49 (9.11%) |
50.78 |
1.51 (3.06%) |
43.50 - 75.34 |
701,134 |
502,990 |
2,006 |
|
|
08-02-2022 |
PM |
6:00 AM ET (Feb 8) |
HAE |
Haemonetics Corporation |
2,350 |
0.84 |
0.75 |
0.81 |
Haemonetics Non-GAAP EPS of $0.84 beats by $0.11, revenue of $259.8M misses by $5.6M [2/8/2022 6:08 AM] |
54.58 |
7.62 (16.21%) |
48.72 |
1.75 (3.73%) |
43.50 - 142.11 |
1,832,379 |
680,000 |
1,661 |
|
|
09-11-2021 |
PM |
6:00 AM ET (Nov 9) |
HAE |
Haemonetics Corporation |
3,700 |
0.60 |
0.63 |
0.62 |
Haemonetics EPS misses by $0.01, misses on revenue [11/9/2021 6:08 AM] |
60.16 |
-10.97 (-15.42%) |
62.00 |
-9.13 (-12.84%) |
49.26 - 142.11 |
1,925,345 |
390,000 |
7,392 |
|
|
11-08-2021 |
PM |
6:00 AM ET (Aug 11) |
HAE |
Haemonetics Corporation |
2,960 |
0.50 |
0.47 |
0.46 |
Haemonetics EPS beats by $0.05, beats on revenue [8/11/2021 6:10 AM] |
61.97 |
4.21 (7.29%) |
57.80 |
0.04 (0.07%) |
49.26 - 142.11 |
1,270,894 |
530,000 |
505 |
|
|
13-05-2021 |
PM |
6:00 AM ET (May 13) |
HAE |
Haemonetics Corporation |
3,030 |
0.46 |
0.67 |
0.69 |
Haemonetics EPS misses by $0.21, beats on revenue [5/13/2021 6:05 AM] |
51.81 |
-8.02 (-13.40%) |
51.81 |
0.0 (0.00%) |
49.26 - 142.11 |
4,761,423 |
920,000 |
1,007 |
|
|
02-02-2021 |
PM |
6:00 AM ET (Feb 2) |
HAE |
Haemonetics Corporation |
5,800 |
0.81 |
0.68 |
0.94 |
Haemonetics EPS beats by $0.16, beats on revenue [2/2/2021 6:07 AM] |
130.11 |
15.11 (13.14%) |
128.00 |
13.00 (11.30%) |
63.41 - 139.69 |
1,194,094 |
587,385 |
1,610 |
|
|
04-11-2020 |
PM |
6:00 AM ET (Nov 4) |
HAE |
Haemonetics Corporation |
5,160 |
0.62 |
0.50 |
0.87 |
Haemonetics EPS beats by $0.11, beats on revenue [11/4/2020 6:03 AM] |
95.42 |
-6.78 (-6.63%) |
102.20 |
0.0 (0.00%) |
63.41 - 130.75 |
683,706 |
490,580 |
8,657 |
|
|
04-08-2020 |
PM |
6:00 AM ET (Aug 4) |
HAE |
Haemonetics Corporation |
4,420 |
0.46 |
0.41 |
0.81 |
Haemonetics EPS beats by $0.05, misses on revenue [8/4/2020 6:04 AM] |
77.51 |
-9.69 (-11.11%) |
83.05 |
-4.15 (-4.76%) |
63.41 - 140.36 |
833,385 |
470,151 |
541 |
|
|
05-05-2020 |
PM |
6:00 AM ET (May 5) |
HAE |
Haemonetics Corporation |
5,590 |
0.69 |
0.73 |
0.61 |
Haemonetics EPS misses by $0.04, misses on revenue [5/5/2020 6:02 AM] |
105.27 |
-4.79 (-4.35%) |
0.0 |
0.0 (0.00%) |
63.41 - 140.36 |
136,744 |
411,503 |
0 |
|
|